X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
34.76%
↑ 229% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-26.85%
Historical baseline
PeriodValue
202534.76%
2024-35.89%
2023-25.09%
2022-7.95%
2021-18.84%
2020-24.78%
2019-17.81%
2018-46.66%
2017-28.56%
2016-97.63%